Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Orchid Pharma LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:524372NSE Symbol: ORCHPHARMAP/E(TTM):59.72
ISIN Demat:INE191A01027Div & Yield %:0EPS(TTM):14.23
Book Value(Rs):264.9747674Market Cap ( Cr.):4310.36Face Value(Rs):10
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 921.93819.37665.90556.97450.70481.21
Excise Duty0.000.000.000.000.000.00
Net Sales921.93819.37665.90556.97450.70481.21
Other Income 31.9330.3958.6456.976.4624.28
Stock Adjustments 43.8543.8921.4822.7315.6920.07
Total Income997.71893.65746.02636.67472.85525.56
EXPENDITURE :      
Raw Materials 588.07528.35406.10336.80244.96220.38
Power & Fuel Cost64.9862.9261.2652.7439.3147.44
Employee Cost 86.3669.6465.3560.2164.4071.60
Other Manufacturing Expenses 42.3232.6529.1926.2624.2640.77
Selling and Administration Expenses 54.7653.1734.9637.7731.5858.78
Miscellaneous Expenses 5.365.467.287.2224.38112.29
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure841.85752.20604.14521.00428.89551.26
Operating Profit155.85141.45141.88115.6743.96-25.71
Interest 14.9316.7132.9033.4652.216.22
Gross Profit140.92124.74108.9882.21-8.25-31.93
Depreciation34.4433.2254.7987.02108.90117.91
Profit Before Tax106.4891.5254.19-4.81-117.15-149.84
Tax0.000.000.000.000.000.00
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax0.00-3.230.000.000.000.00
Reported Net Profit106.4894.7554.19-4.81-117.15-149.84
Extraordinary Items -0.32-0.1940.000.510.980.09
Adjusted Net Profit106.8094.9414.19-5.32-118.13-149.93
Adjst. below Net Profit 0.000.000.000.000.0088.56
P & L Balance brought forward-1988.38-2082.68-2136.64-2133.29-2016.74-1953.57
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 0.700.450.23-1.46-0.601.89
P & L Balance carried down-1882.60-1988.38-2082.68-2136.64-2133.29-2016.74
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %0.000.000.000.000.000.00
Earnings Per Share-Unit Curr20.9918.6813.28-1.18-28.70-36.71
Earnings Per Share(Adj)-Unit Curr20.9918.6813.28-1.18-28.70NA
Book Value-Unit Curr247.54226.69162.53149.30150.13178.67